Robert Wellman, MS
“Being part of Kaiser Permanente research teams gives me a chance to develop cutting-edge biostatistical methods while contributing to health care research with a national impact.”
Robert Wellman, MS
Principal Collaborative Biostatistician, Kaiser Permanente Washington Health Research Institute
Robert.D.Wellman@kp.org
206-287-2557
Biography
A graduate of the University of Washington (UW) biostatistics program, Robert Wellman, MS, joined the Kaiser Permanente Washington Health Research Institute (KPWHRI) Biostatistics Unit in 2009. His work spans a diverse collection of topics including mental health, pharmacoepidemiology, postmarketing drug safety surveillance, obesity, diagnostic test accuracy, back pain, and breast cancer. Prior to this, he spent 5 years in the Biostatistics Core at the UW Center for AIDS Research.
Research interests and experience
-
Biostatistics
Causal inference; longitudinal data; diagnostic and screening test accuracy; clinical trials; survival analysis: rare disease outcomes; nonparametrics; missing data; electronic data; distributed data; statistical computing
Vaccines & Infectious Diseases
Biostatistics; HIV/AIDS; vaccine safety
Complementary & Integrative Health
Biostatistics; clinical trials; back pain
Obesity
Biostatistics; bariatric surgery
-
Cancer
Biostatistics; breast cancer; effects of chemotherapy; accuracy of automated data; screening test accuracy; advanced imaging
Medication Use & Patient Safety
Biostatistics; pharmacoepidemiology; postmarketing drug safety surveillance; big data; electronic health record and claims data
Mental Health
Biostatistics; suicide risk prediction, machine learning
Recent publications
Sherman KJ, Cook AJ, Kahn JR, Hawkes RJ, Wellman RD, Cherkin DC. Dosing study of massage for chronic neck pain: protocol for the dose response evaluation and analysis of massage [DREAM] trial. BMC Complement Altern Med. 2012;12:158. PubMed
Bowles EJ, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, Allen LA, Nekhlyudov L, Goddard KA, Davis RL, Habel LA, Yood MU, Magid D, Wagner EH, for the Pharmacovigilance Study Team. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst. 2012 Sep 5;104(17):1293-305. PubMed
Arterburn D, Wellman R, Westbrook E, Rutter C, Ross T, McCulloch D, Handley M, Jung C. Introducing decision aids at Group Health was linked to sharply lower hip and knee surgery rates and costs. Health Aff (Millwood). 2012;31(9):2094-104. PubMed
Allen LA, Yood MU, Wagner EH, Aiello Bowles EJ, Pardee R, Wellman R, Habel L, Nekhlyudov L, Davis RL, Onitilo AA, Magid DJ; for the Pharmacovigilance Research Group. Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer. Med Care. 2014 May;52(5):e30-8. doi: 10.1097/MLR.0b013e31825a8c22. Epub 2012 May 25. PubMed
Delate T, Bowles EJ, Pardee R, Wellman RD, Habel LA, Yood MU, Nekhlyudov L, Goddard KA, Davis RL, McCarty CA, Onitilo AA, Feigelson HS, Freml J, Wagner E. Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure. Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):673-80. Epub 2012 Feb 15. PubMed
New findings
Simpler models to identify suicide risk perform similarly to more complex ones
Models that are easier to explain, use could have better uptake in health care settings.
Research
Phone therapy for insomnia shown to improve sleep
A study among KP members with sleep problems and osteoarthritis shows promise for overcoming obstacles to treatment.
healthy findings blog
Best weight-loss surgery for diabetes and severe obesity?
Watch video on latest results from PCORnet Bariatric Study. (Spoiler alert: Bypass, not sleeve.)
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.